Institutional investors purchased a net $3.2 million shares of ATRS during the quarter ended September 2017. This may signal that the smart money is gaining interest in this company as the 34.80% of shares outstanding that institutional investors hold is actually below the Medical Specialties industry average.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
FIAM LLC Bought 2.9 Million shares of Antares Pharma Inc
SSGA FUNDS MANAGEMENT, INC. Bought 609.2 Thousand shares of Antares Pharma Inc
PANAGORA ASSET MANAGEMENT, INC. Bought 403.5 Thousand shares of Antares Pharma Inc